Cite
Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations
MLA
C. Perronne, et al. “Lipodystrophy Defined by a Clinical Score in HIV-Infected Men on Highly Active Antiretroviral Therapy: Correlation between Dyslipidaemia and Steroid Hormone Alterations.” AIDS, vol. 13, Nov. 1999, pp. 2251–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....696b21e3e7e3afaf570defda84b51adc&authtype=sso&custid=ns315887.
APA
C. Perronne, P. De Truchis, Névéna Christeff, Jean-Claude Melchior, Marie-Lise Gougeon, & E. A. Nunez. (1999). Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS, 13, 2251–2260.
Chicago
C. Perronne, P. De Truchis, Névéna Christeff, Jean-Claude Melchior, Marie-Lise Gougeon, and E. A. Nunez. 1999. “Lipodystrophy Defined by a Clinical Score in HIV-Infected Men on Highly Active Antiretroviral Therapy: Correlation between Dyslipidaemia and Steroid Hormone Alterations.” AIDS 13 (November): 2251–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....696b21e3e7e3afaf570defda84b51adc&authtype=sso&custid=ns315887.